Intervention

ABBV-927

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting0

Common conditions6

Lead sponsors shown1

Clinical trials

2 shown

A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Participants With Locally Advanced or Metastatic Solid TumorsNCT03893955 · 2019-05-21

ACTIVE_NOT_RECRUITING

A Study of ABBV-927 and ABBV-181, an Immunotherapy, in Participants With Advanced Solid TumorsNCT02988960 · 2017-02-22

ACTIVE_NOT_RECRUITING

Common conditions

Advanced Solid Tumors1 Advanced Solid Tumors Cancer1 Cancer1 Metastatic Solid Tumors1 Non-small-cell-lung-cancer (NSCLC)1 Triple-Negative Breast Cancer (TNBC)1

Leading sponsors

Trial status mix

ACTIVE_NOT_RECRUITING2

Phase mix

PHASE12

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.